Physiologic concentrations of arginine vasopressin activate human platelets in vitro

British Journal of Haematology

Volumn 92, Issue 4, 1996, Pages 968-972

  Wun, Ted ^a,b,d   Paglieroni, Teresa ^b   Lachant, Neil A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sacramento Tree Foundation   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

arginine vasopressin; flow cytometry; P selectin

Indexed keywords

ARGIPRESSIN; PADGEM PROTEIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0029940596     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.436975.x     Document Type: Article

References (44)

1. Abrams, C.A. & Shattil, S.J. (1991) Immunological detection of activated platelets in clinical disorders. Thrombosis and Hemostasis. 65, 467-473.
2. Argawal, K.C. (1993) Modulation of vasopressin actions on human platelets by plasma adenosine and theophylline: gender differences. Journal of Cardiovascular Pharmacology, 21, 1012-1018.
3. Ault, K.A., Rinder, H.M., Mitchell, J.G., Rinder, C.S., Labrew, C.T. & Hillman, R.S. (1989) Correlated measurement of platelet release and aggregation in whole blood. Cytometry, 10, 448-455.
4. Berretini, W.H., Post, R.M., Worthington, E.K. & Casper J.B. (1982) Human platelet vasopressin receptors. Life Sciences, 30, 425-432.
5. Bichet, D.G., Mathus, M.F., Barjon, J.N., Lonegran, M. & Kortas, C. (1987) Human platelet fraction arginine-vasopressin: potential physiologic role. Journal of Clinical Investigation, 79, 881-887.
6. Burns, S.M., Martin, M., Merrill, P., Luer, J. & Stone, D.D. (1993) Evaluation and revision of a vasopressin/nitroglycerin protocol for use in variceal bleeding. American Journal of Critical Care, 2, 202-207.
7. Chesney, C.M., Crofton, J.T., Pifer, D.D., Brooks, D.P., Hutch, K.M. & Share, L. (1985) Subcellular localization of vasopressin-like material in platelets. Journal of Laboratory and Clinical Medicine, 106, 314-318.
8. DiTuillio, N.W., Kinter, L.B. & Storer, B.L. (1985) Pharmacological characterization of vasopressin aggregation response of human platelets. Thrombosis Research, 40, 425-432.
9. Dominiczak, A.F., Morton, J.J., Murray, G. & Semple, P.F. (1989) Platelet cytosolic free calcium in essential hypertension: response to vasopressin. Clinical Science, 77, 183-188.
10. Goff, J.S. (1993) Gastroesophageal varices: pathogenesis and therapy of acute bleeding. Gastroenterology Clinics of North America, 22, 779-800.
11. Grant, P.J., Davies, J.A., Tate, G.M., Boothby, M. & Prentice, C.R.M. (1985) Effects of physiological concentrations of vasopressin on haemostatic function in man. Clinical Science, 69, 471-476.
12. Hallam, T.J., Thompson, N.T., Scrutton, M.C. & Rink, T.J. (1984) The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin. Biochemical Journal, 221, 897-901.
13. Hays, R.M. (1985) Agents affecting the renal conservation of water. The Pharmacologic Basis of Therapeutics, 7th edn (ed. by A. G. Gilman, L. S. Goodman, T. W. Wall and F. Murad), pp. 908-919, Macmillan, New York.
14. Inaba, K., Umeda, Y., Yamane, Y., Urakami, M. & Inada, M. (1988) Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets. Clinical Endocrinology, 29, 337-386.
15. Inaba, K., Umeda, Y., Yamane, Y., Urakami, M., Nagata, M. & Inada, M. (1989) Platelet vasopressin receptor in patients with chronic renal failure. Japan Journal of Nephrology, 31, 79-84.
16. Jard, S. (1988) Mechanisms of action of vasopressin and antagonists. Kidney International, 34, S38-S42.
17. Kroll, M.H. & Schafer, A.I. (1989) Biochemical mechanisms of platelet activation. Blood, 74, 1181-1195.
18. Lachant, N.A., Smith, M.R., Xie, Z.J. & Romani, W.R. (1995) Heterogeneity of the aggregation response of human platelets to arginine vasopressin. American Journal of Hematology, 49, 56-66.
19. Launay, J.M., Vittet, D., Vidaud, M., Rondot, A., Mathieu, M.N., Lalau-Keraly, C., Cantau, B. & Chevillard, C. (1987) VIa-vasopressin specific receptors of human platelets: potentiation by ADP and epinephrine and evidence for homologous down-regulation. Thrombosis Research, 45, 323-331.
20. Manning, M., Bankowski, K. & Sawyer, W.H. (1988) Selective agonists and antagonists of vasopressin. Vasopressin (ed. by D. M. Gash and G. J. Bower), pp. 335-368. Plenum Press, New York.
21. Mannuci, P.M., Aberg, M., Nilsson, B. & Robertson, B. (1975) Mechanism of plasminogen and factor VIII increase after vasoactive drugs. British Journal of Haematology, 30, 81-93.
22. McEver, R.P. (1990) Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells, 16, 73-83.
23. Nussey, S.S., Ang, V.T.Y. Bevan, D.H. & Jenkins, J.S. (1986a) Human platelet arginine vasopressin. Clinical Endocrinology, 24, 427-433.
24. Nussey, S.S., Bevan, D.H., Ang, V.T.Y. & Jenkins, J.S. (1986b) Effects of arginine vasopressin (AVP) infusions on circulating concentrations of platelet AVP, factor VIII: C and von Willebrand factor. Thrombosis and Haemostasis, 55, 34-36.
25. Padfield, P.L., Brown, J.J., Lever, A.F. & Morton, J.J. (1976) Changes of vasopressin in hypertension: cause or effect? Lancet, i, 1255-1257.
26. Padfield, P.L., Brown, J.J., Lever, A.F., Morton, J.J. & Robertson, J.I.S. (1981) Blood pressure in acute and chronic vasopressin excess, studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion. New England Journal of Medicine, 304, 1067-1070.
27. Parmentier, S., McGregor, L., Catimel, B., Leung, L.L.K. & McGregor, J.L. (1991) Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane protein (GMP-140/PADGEM). Blood, 77, 1734-1739.
28. Pollock, W.K. & MacIntyre, D.E. (1986) Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets. Biochemical Journal, 234, 67-73.
29. Preibisz, J.J., Sealy, J.J., Laragh, J.H., Cody, R.J. & Weskler, B.B. (1983) Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension, (Suppl. 1), I-129-I-138.
30. Ready, J.B., Robertson, A.D. & Rector, W.G., Jr (1991) Effects of vasopressin on portal pressure during hemorrhage from esophageal varices. Gastroenterology, 100, 1411-1416.
31. Rinder, H.M., Snyder, E.L., Bonan, J.L., Napychank, P.A., Malkus, H. & Smith, B.R. (1995) Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and β-thromboglobulin release. Transfusion, 33, 25-29.
32. Siess, W., Stifel, M., Binder, U. & Weber, P.C. (1986) Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets. Biochemical Journal, 223, 83-91.
33. Thibonnier, M. (1990) Vasopressin agonists and antagonists. Hormone Research, 34, 124-128.
34. Thibonnier, M. & Roberts, J. (1985) Characterization of human platelet vasopressin receptors. Journal of Clinical Investigation, 76, 1857-1864.
35. Thibonnier, M. & Woloschak, M. (1988) Platelet aggregation and vasopressin receptors in patients with diabetes mellitus. Proceedings of the Society for Experimental Biology and Medicine, 188, 142-149.
36. Thibonnier, M., Hinko, A. & Pearlmutter, A.F. (1987) The human platelet vasopressin receptor and its intracellular messengers: key role of divalent cations. Journal Cardiovascular Pharmacology, 10, 24-29.
37. Thomas, M.E., Osmani, A.H. & Scrutton, M.C. (1983) Some properties of the human platelet vasopressin receptor. Thrombosis Research, 32, 557-566.
38. Vittet, D., Launay, J.M. & Chevillard, C. (1989) Homologous regulation of human platelet vasopressin receptors does not occur in vivo. American Journal of Physiology, 257, 1400-1405.
39. Vittet, D., Rondot, A., Cantau, B., Launay, J.M. & Chevillard, C. (1986) Nature and properties of human vasopressin receptors. Biochemical Journal, 233, 631-636.
40. Wun, T., Paglieroni, T. & Lachant, N.A. (1993) Inhibition effect of a V1 receptor antagonist on vasopressin-induced platelet aggregation but not activation. Clinical Research, 41, 20a.
41. Wun, T., Paglieroni, T. & Lachant, N.A. (1995) Desmopressin stimulated the expression of P-selectin on human platelets in vitro Journal of Laboratory and Clinical Medicine, 125, 401-409.
42. Wun, T., Paglieroni, T., Sazama, K. & Holland, P. (1992) Detection of plasmapheresis-induced platelet activation using monoclonal antibodies. Transfusion, 32, 534-540.
43. Yang, X., Disa, J. & Rao, A.K. (1990) Effect of 1-desamino-8-d-arginine vasopressin (ddavp) on human platelets. Thrombosis Research, 59, 809-818.
44. Zerez, C.R., Lachant, N.A., Lent, K.M. & Tanaka, K.R. (1992) Decreased pyrimidine nucleoside monophosphate kinase activity in sickle erythrocytes. Blood, 80, 512-516.